Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils

被引:5
|
作者
Svensson, Lena [1 ]
Redvall, Elin [1 ]
Johnsson, Marianne [1 ]
Stenfeldt, Anna-Lena [1 ]
Dahlgren, Claes [2 ]
Wenneras, Christine [1 ,3 ]
机构
[1] Gothenburg Univ, Dept Clin Bacteriol, Gothenburg, Sweden
[2] Gothenburg Univ, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Hematol & Coagulat, S-41345 Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
respiratory burst; chemotaxis; eotaxin-1 (CCL11); desensitization; PROTEIN-COUPLED RECEPTORS; RESPIRATORY BURST; HUMAN NEUTROPHILS; CYCLOSPORINE-A; ACTIVATION; RESPONSES; FORMYL-PEPTIDE-RECEPTOR-LIKE-1; DESENSITIZATION; INHIBITION; MIGRATION;
D O I
10.1189/jlb.0908514
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Eosinophils express the chemoattractant receptors CCR3 and FPR. CCR3 binds several agonists such as eotaxin-1, -2, and -3 and RANTES, whereas the FPR binds the formylated tripeptide fMLP and a host of other ligands. The aim of this study was to investigate if there is interplay between these two receptors regarding the elicitation of migration and respiratory burst in human blood-derived eosinophils. Inhibition of the FPR with the antagonists CyH and boc-MLP abrogated the migration of eosinophils toward all of the CCR3 agonists. Similar results were seen when the FPR was desensitized with its cognate ligand, fMLP. In contrast, the respiratory burst triggered by eotaxin-1 was not inhibited by CyH. Thus, signals evoked via the FPR caused unidirectional down-regulation of CCR3-mediated chemotaxis but not respiratory burst in human eosinophils. The underlying mechanism was neither reduced ability of the CCR3 ligand eotaxin-1 to bind to CCR3 nor down-regulation of CCR3 from the cell surface. Finally, confocal microscopy and adFRET analysis ruled out homo- or heterodimer formation between FPR and/or CCR3 as an explanation for the reduction in chemotaxis via CCR3. Pharmacologic inhibition of signal transduction molecules showed that the release of free oxygen radicals in response to eotaxin-1 compared with fMLP is relatively more dependent on the p38 MAPK pathway. J. Leukoc. Biol. 86: 327-336; 2009.
引用
收藏
页码:327 / 336
页数:10
相关论文
共 50 条
  • [21] In Silico Identification of Cholesterol Binding Motifs in the Chemokine Receptor CCR3
    van Aalst, Evan
    Koneri, Jotham
    Wylie, Benjamin J.
    MEMBRANES, 2021, 11 (08)
  • [22] Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways
    Sabroe, I
    Hartnell, A
    Jopling, LA
    Bel, S
    Ponath, PD
    Pease, JE
    Collins, PD
    Williams, TJ
    JOURNAL OF IMMUNOLOGY, 1999, 162 (05): : 2946 - 2955
  • [23] Chemokine receptor CCR3 is important for migration of mast cells in neurofibroma
    Tai, Wei-Chun
    Wang, Sin-Ting
    Wu, Chieh-Shan
    Lin, Tze-Yi
    Wu, Meng-Tse
    DERMATOLOGICA SINICA, 2010, 28 (04) : 146 - 153
  • [24] Conserved sequence and tissue expression of the rat CCR3 chemokine receptor
    Flanagan, BF
    Harrington, PM
    Newton, DJ
    Coleman, JW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S42 - S43
  • [25] Functional analysis of the chemokine receptor CCR3 on airway epithelial cells
    Beck, Lisa A.
    Tancowny, Brian
    Brummet, Mary E.
    Asaki, S. Yukiko
    Curry, Stephanie L.
    Penno, Margaret B.
    Foster, Martyn
    Bahl, Ash
    Stellato, Cristiana
    JOURNAL OF IMMUNOLOGY, 2006, 177 (05): : 3344 - 3354
  • [26] Detection of the chemokine receptor CCR3 on endothelial cells and keratinocytes.
    Lee, SC
    Brummet, ME
    Sholl, L
    Plitt, JR
    MacGlashan, DW
    Ponath, PD
    Schleimer, RP
    Beck, LA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S194 - S194
  • [27] Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency
    De Lucca, GV
    Kim, UT
    Vargo, BJ
    Duncia, JV
    Santella, JB
    Gardner, DS
    Zheng, CS
    Liauw, A
    Wang, Z
    Emmett, G
    Wacker, DA
    Welch, PK
    Covington, M
    Stowell, NC
    Wadman, EA
    Das, AM
    Davies, P
    Yeleswaram, S
    Graden, DM
    Solomon, KA
    Newton, RC
    Trainor, GL
    Decicco, CP
    Ko, SS
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2194 - 2211
  • [28] Expression of eotaxin and the CCR3 receptor in human atheroma
    Haley, KJ
    Lilly, CM
    Yang, JH
    Kennedy, SP
    Turi, TG
    Thompson, JF
    Sukhova, GK
    Libby, P
    Lee, RT
    CIRCULATION, 1999, 100 (18) : 543 - 543
  • [29] Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma
    Jöhrer, K
    Zelle-Rieser, C
    Perathoner, A
    Moser, P
    Hager, M
    Ramoner, R
    Gander, H
    Höltl, L
    Bartsch, G
    Greil, R
    Thurnher, M
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2459 - 2465
  • [30] Expression of chemokine receptor CCR5 and CCR3 in Type 1 diabetes mellitus
    Liu, Y
    Chen, J
    Liu, C
    DIABETOLOGIA, 2002, 45 : A119 - A119